Reteplase with or without Abciximab for Peripheral Arterial Occlusions: Efficacy and Adverse Events

Hull, Jeffrey E.; Hull, Mary Kathryn; Urso, James A.

doi:10.1097/01.rvi.0000127891.54811.02

Cited by 15 publications

(3 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Fibrinogen is depleted during thrombolysis, and its measurement could be used to predict bleeding complications or guide the dose of thrombolytic agent. 117 While the Surgery vs. Thrombolysis for Ischaemia of the Lower Extremity (STILE) trial reported a correlation between low fibrinogen and haemorrhagic complications, 91 the Prourokinase vs. Urokinase for Recanalisation of Peripheral Occlusions, Safety and Efficacy (PURPOSE) trial found a negative correlation for low fibrinogen and major bleeding but a relative risk of 1.39 for plasma fibrinogen < 1.0 g/L and any bleeding.…”

Section: Monitoring Fibrinogen Levels During Thrombolysismentioning

confidence: 99%

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia

Björck

Earnshaw

Acosta

et al. 2020

European Journal of Vascular and Endovascular Surgery

336

222

View full text Add to dashboard Cite

Section: Monitoring Fibrinogen Levels During Thrombolysismentioning

confidence: 99%

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia

Björck

Earnshaw

Acosta

et al. 2020

European Journal of Vascular and Endovascular Surgery

336

222

View full text Add to dashboard Cite

“…The frequency of bleeding complications was either equivalent or higher. 29,31,[36][37][38][39] Experience with tirofiban and eptifibatide is more limited. 40 Use of these agents in peripheral arterial CDT has not been widely adopted given the results so far.…”

Section: Adjunctive Pharmaceuticalsmentioning

confidence: 99%

Catheter-Directed Thrombolysis for Acute Limb Ischemia

Morrison

2006

Semin intervent Radiol

View full text Add to dashboard Cite

Acute limb ischemia is a potentially life-threatening clinical event. Thrombosis in situ, bypass graft thrombosis, and embolic occlusion are the three major precipitating events leading to acute limb ischemia. Management of acute ischemia depends on the clinical status of the affected limb and patient comorbidities. Catheter-directed thrombolysis (CDT) is the treatment of choice for patients with relatively mild acute limb ischemia (Rutherford categories I and IIa) with no contraindications to thrombolytic therapy. Patients with severe acute limb ischemia (Rutherford category IIb) need emergent revascularization. CDT should be considered, nonetheless, if the relative risks compared with primary operation are favorable. CDT is a life-and limb-saving treatment for many patients despite limitations of efficacy and associated complications. This article is a review of the etiology of acute arterial occlusion; clinical triage of patients presenting with acute limb ischemia; catheter guide wire techniques, pharmacological agents, and devices in current use for CDT; as well as the outcomes of CDT.

show abstract

“…Sau 48 giờ chụp MSCT mạch máu kiểm tra thấy động mạch đùi nông -khoeo -chày trước và động mạch mác phải bắt thuốc tốt, động mạch chày sau tắc hoàn toàn do vôi hóa nặng. [4,10,11].…”

Section: Liều đIều Trị Của Tiêu Sợi Huyết Qua ốNg Thông(catheter Dicrunclassified

Điều trị thiếu máu chi cấp tính bằng thuốc tiêu sợi huyết động mạch trực tiếp qua ống thông

Nút¹,

Nghĩa²,

Hạnh³

et al. 2020

VJCTS

View full text Add to dashboard Cite

Bệnh nhân được sử dụng thuốc tiêu sợi huyết (urokinase) trực tiếp qua ống thông điều trị tắc động mạch đùi nông và động mạch khoeo cấp tính, trong đó có 01 trường hợp can thiệp nội mạch đặt stent động mạch đùi nông kết hợp. Sau 24 giờ rút ống thông với kết quả chi bệnh nhân ấm, vận động cảm giác bình thường, siêu âm Doppler và chụp MSCT ghi nhận động mạch tái thông tốt, không trường hợp nào biến chứng. Điều trị bệnh thiếu máu chi cấp tính(ALI) bằng thuốc tiêu sợi huyết trực tiếp qua ống thông là phương pháp điều trị an toàn, hiệu quả và ít biến chứng.

show abstract

Reteplase with or without Abciximab for Peripheral Arterial Occlusions: Efficacy and Adverse Events

Cited by 15 publications

References 35 publications

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia

Catheter-Directed Thrombolysis for Acute Limb Ischemia

Điều trị thiếu máu chi cấp tính bằng thuốc tiêu sợi huyết động mạch trực tiếp qua ống thông

Contact Info

Product

Resources

About